Emergent BioSolutions Inc. EBS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.43% | -47.74% | 7.51% | 106.43% | 63.78% |
| Total Receivables | -48.16% | 138.10% | -40.30% | -45.50% | 23.25% |
| Inventory | -21.16% | -10.34% | 4.33% | 10.17% | 10.41% |
| Prepaid Expenses | -10.55% | 5.83% | -10.93% | -4.09% | -58.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -88.00% | -25.51% | -87.76% | -39.34% | 53.85% |
| Total Current Assets | -29.06% | -7.44% | -9.79% | 10.66% | 18.97% |
|
|
|||||
| Total Current Assets | -29.06% | -7.44% | -9.79% | 10.66% | 18.97% |
| Net Property, Plant & Equipment | -16.96% | -17.87% | -8.04% | -23.49% | -25.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -44.22% | -44.18% | -3.05% | -12.96% | -12.57% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.27% | 8.33% | -52.31% | -50.00% | -45.68% |
| Total Assets | -31.88% | -21.19% | -7.41% | -5.12% | -1.14% |
|
|
|||||
| Total Accounts Payable | -9.41% | -21.19% | -32.01% | -8.70% | -30.09% |
| Total Accrued Expenses | -17.62% | -3.99% | -17.15% | -26.83% | -36.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -16.67% | -16.67% | 26.32% | -11.11% | -48.57% |
| Total Finance Division Other Current Liabilities | 0.37% | 68.48% | 438.57% | -19.20% | -58.71% |
| Total Other Current Liabilities | 0.37% | 68.48% | 438.57% | -19.20% | -58.71% |
| Total Current Liabilities | -10.62% | -3.38% | 32.89% | -18.60% | -40.63% |
|
|
|||||
| Total Current Liabilities | -10.62% | -3.38% | 32.89% | -18.60% | -40.63% |
| Long-Term Debt | -23.44% | -12.88% | -13.84% | -13.80% | 0.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -26.23% | -24.62% | 68.63% | -5.15% | -42.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -34.34% | -17.11% | -26.79% | 16.03% | 8.66% |
| Total Liabilities | -22.37% | -11.98% | -8.71% | -12.23% | -9.38% |
|
|
|||||
| Common Stock & APIC | 1.92% | 1.77% | 1.47% | 1.55% | 1.54% |
| Retained Earnings | -247.81% | -113.04% | -5.96% | 24.76% | 41.91% |
| Treasury Stock & Other | -10.60% | -14.26% | -14.84% | -11.68% | -6.81% |
| Total Common Equity | -46.23% | -36.33% | -5.36% | 8.24% | 14.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -46.23% | -36.33% | -5.36% | 8.24% | 14.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -46.23% | -36.33% | -5.36% | 8.24% | 14.58% |
|
|
|||||